Search Results - "Oei, Angèle L M"

Secondary ovarian malignancies: frequency, origin, and characteristics by de Waal, Yvonne R P, Thomas, Chris M G, Oei, Angèle L M, Sweep, Fred C G J, Massuger, Leon F A G

“…To evaluate the frequency of metastatic tumors among malignant ovarian neoplasms, the site distribution of the primary malignancies that give rise to ovarian…”
Get more information

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome by Gerritzen, Lotte H. M., Hoogerbrugge, Nicoline, Oei, Angèle L. M., Nagengast, Fokko M., van Ham, Maaike A. P. C., Massuger, Leon F. A. G., de Hullu, Joanne A.

“…In women with hereditary non polyposis colorectal carcinoma (HNPCC) an annual gynaecological surveillance has been recommended because of an increased lifetime…”
Get full text

The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (Review) by OEI, Angèle L. M, SWEEP, Fred C. G. J, THOMAS, Chris M. G, BOERMAN, Otto C, MASSUGER, Leon F. A. G

“…The prognosis for patients with ovarian cancer is still poor and more effective therapeutic modalities are needed. (Radio)immunotherapy using monoclonal…”
Get full text

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer by Oei, Angèle L.M., Moreno, María, Verheijen, René H.M., Sweep, Fred C.G.J., Thomas, Chris M.G., Massuger, Leon F.A.G., von Mensdorff‐Pouilly, Silvia

“…We investigated whether epithelial ovarian cancer patients participating in a randomized phase III trial comparing single intraperitoneal (IP) administration…”
Get full text

Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody by Oei, Angèle L.M, Sweep, Fred C.G.J, Massuger, Leon F.A.G, Olthaar, André J, Thomas, Chris M.G

“…Abstract Objective To investigate the influence of human anti-mouse antibodies (HAMA) on serial CA 125 measurements in serum of patients with epithelial…”
Get full text

First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants by Gelderblom, Malou E., Jaspers, Veerle, Akkermans, Reinier P., Slangen, Brigitte, Oei, Angele L. M., Ginkel, Alexandra A., Ngo, Huy, IntHout, Joanna, Hermens, Rosella P. M. G., Hullu, Joanne A., Piek, Jurgen M. J.

“…Introduction Opportunistic salpingectomy (OS) refers to additional removal of the fallopian tubes during abdominal surgery performed for another medical…”
Get full text

Human Anti-mouse IgM and IgG Responses in Ovarian Cancer Patients after Radioimmunotherapy with 90Y-muHMFG1 by OEI, Angèle L. M, SWEEP, Fred C. G. J, GEURTS-MOESPOT, Anneke, VAN TIENOVEN, Doorlène, VON MENSDORFF-POUILLY, Silvia, THOMAS, Chris M. G, MASSUGER, Leon F. A. G

“…Background: Human anti-mouse antibody (HAMA)-IgM and IgG in ovarian cancer patients treated with intraperitoneal (i.p.) 90 Y-muHMFG1 as consolidating therapy…”
Get full text

Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer by Oei, Angèle L M, Massuger, Leon F A G, Oyen, Wim J G

“…We conducted a single-arm study to determine the biodistribution of intraperitoneally (i.p.) administered 90yttrium-labeled murine monoclonal antibody HMFG1…”
Get more information

Effect of single‐ versus double‐layer uterine closure during caesarean section on postmenstrual spotting (2Close): multicentre, double‐blind, randomised controlled superiority trial by Stegwee, SI, Voet, LF, Ben, AJ, Leeuw, RA, Ven, PM, Duijnhoven, RG, Bongers, MY, Lambalk, CB, Groot, CJM, Huirne, JAF, Papatsonis, Dimitri NM, Pajkrt, Eva, Hehenkamp, Wouter JK, Oei, Angèle LM, Bekker, Mireille N, Schippers, Daniela H, van Vliet, Huib AAM, van der Voet, Lucet, Schuitemaker, Nico WE, Hemelaar, Majoie, van Baal, WM (Marchien), Huisjes, Anjoke JM, Meijer, Wouter J, Janssen, CAH (Ineke), Hermes, Wietske, Feitsma, AH (Hanneke), van Eijndhoven, Hugo WF, Rijnders, Robbert JP, Sueters, Marieke, Scheepers, HCJ (Liesbeth), van Laar, Judith OEH, Boormans, Elisabeth MA, van Kesteren, Paul JM, Radder, Celine M, Hink, Esther, Kapiteijn, Kitty, de Boer, Karin, Kaplan, Mesrure, van Beek, Erik, de Vleeschouwer, LHM (Marloes), Visser, Harry, Bosmans, Judith E, El Alili, Mohamed, Langenveld, Josje

“…Objective To evaluate whether double‐layer uterine closure after a first caesarean section (CS) is superior compared with single‐layer uterine closure in terms…”
Get full text

Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial by Stegwee, Sanne I., Ben, Ângela J., El Alili, Mohamed, van der Voet, Lucet F., de Groot, Christianne J.M., Bosmans, Judith E., Huirne, Judith A.F.

“…ObjectiveTo evaluate the cost-effectiveness of double-layer compared with single-layer uterine closure after a first caesarean section (CS) from a societal and…”
Get full text